T.J.Y. Tan

Statistics

Publications

Citations

104

H-Index

Active since

2021

Affiliations

Sarah Cannon Research Institute(Current)

T.J.Y. Tan is an author at Sarah Cannon Research Institute specializing in her2-positive breast cancer immunotherapy, her2-positive breast cancer therapy, and her2 inhibitors.

Publications per year

2021–2021

Publications

LBA15 Primary outcome of the phase III SYD985.002/TULIP trial comparing [vic-]trastuzumab duocarmazine to physician’s choice treatment in patients with pre-treated HER2-positive locally advanced or metastatic breast cancer

C. Saura Manich, Joyce O’Shaughnessy, Philippe Aftimos et al. · Annals of Oncology · 2021 · 104 citations

Medicine, Oncology, Pharmacology +15

1–1 of 1